AdvanSix Inc.
Close on Oct 19, 2026
- Market cap
- $443.01M
- P/E (TTM)
- –
- Dividend yield
- –
About AdvanSix
Plastic Materials, Synth Resins & Nonvulcan Elastomers, SIC 2821
AdvanSix Inc. is an integrated chemistry company that manufactures essential materials across three primary product lines: nylon solutions, plant nutrients, and chemical intermediates. Its portfolio includes Nylon 6 polymer resins, caprolactam monomer, ammonium sulfate fertilizers, and various intermediate chemicals such as acetone, phenol, and alkyl-amines. The company functions as a single operating and reportable segment, serving approximately 375 customers each year across global supply chains. Key end-market industries include building and construction, agriculture, plastics, coatings, solvents, electronics, and automotive manufacturing.
The company operates five production facilities within the United States, situated in Frankford, Pennsylvania; Hopewell, Chesterfield, and Portsmouth, Virginia; and Bucks, Alabama. Its primary fertilizer and caprolactam operations are centered at the Hopewell complex, while nylon polymerization occurs in Chesterfield. Although AdvanSix serves domestic and international markets, the majority of its customer base resides within the United States. Corporate headquarters are located in Parsippany, New Jersey.
Summary of the business section of AdvanSix's latest annual report, written by StockData.
Company profile
Company
- Legal name
- AdvanSix Inc.
- Founded
- 2016
- Headquarters
- Parsippany, NJ
- Address
- 300 Kimball Drive, Suite 101 07054
- Phone
- (973) 526-1800
- Employees
- 1,410, Dec 31, 2025
- Industry
- Plastic Materials, Synth Resins & Nonvulcan Elastomers
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- PricewaterhouseCoopers LLP, Florham Park, NJ
Stock & identifiers
- Ticker
- ASIX
- Exchange
- NYSE
- Shares outstanding
- 27M, Jul 31, 2026
- Public float
- $622.00M, Jun 30, 2025
- Filer category
- Large accelerated filer
- SEC CIK
- 1673985
- CUSIP
- 00773T101
- ISIN
- US00773T1016
- LEI
- 5493009TPRODMCAZLF67
- EIN
- 81-2525089
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Erin N. Kane | Chief Executive Officer, Director | 623,103 |
| Patrick C. Day | SVP, CFO | 38,038 |
| Rachael E. Ryan | VP, Controller | 16,513 |
| Christopher Gramm | VP and Interim CFO | 73,025 |
| Kelly Slieter | SVP, Chief HR Officer | 65,029 |
| Achilles B. Kintiroglou | SVP, General Counsel | 50,363 |
| Siddharth Manjeshwar | SVP & Chief Financial Officer | 40,852 |
| Patrick Williams | Director | 43,434 |
| Todd D. Karran | Director | 91,946 |
| Sharon Spurlin | Director | 80,953 |
| Daryl Roberts | Director | 6,207 |
| Dana C. O'Brien | Director | 6,207 |
| Gena C. Lovett | Director | 21,369 |
| Jeffrey J. Bird | Director | 6,207 |
| Donald P. Newman | Director | 21,513 |
| Daniel F. Sansone | Director | 67,767 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Erin N. Kane | $5.65M | $531.23K | $1.49M | $95 | $154 |
| FY2024 Erin N. Kane | $5.59M | $6.73M | $1.31M | $151 | $135 |
| FY2023 Erin N. Kane | $4.72M | $513.70K | $1.12M | $155 | $133 |
| FY2022 Erin N. Kane | $5.32M | $1.39M | $1.16M | $193 | $111 |
| FY2021 Erin N. Kane | $5.75M | $23.02M | $1.42M | $237 | $118 |
| FY2020 Erin N. Kane | $4.39M | $4.50M | $1.08M | $100 | $123 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of December 31, 2025, the Company employed approximately 1,410 people.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| May 12, 2016 | Spin-off | Registration as a new public company (Form 10), e.g. spin-off |